3mg of retatrutide 30mg Triple-Receptor Metabolic Research Peptide – BioPeptics GLP-3 RT – True Lab
Description
Most patients lose 1-2kg monthly during the titration phase, accelerating to 2-4kg monthly at therapeutic doses
Rabiei M, Kashanian S, Bahrami G, Derakhshankhah H, Barzegari E, Samavati SS, et al
A combination product, Qsymia (phentermine plus topiramate), is also available for extended treatment
While brand-name Ozempic carries FDA approval, compounded versions are not FDA-approved but are legally produced under pharmaceutical-grade oversight
However, the Trump administration recently announced plans to expand Medicare coverage for GLP-1s under a pilot program
